Economic Impact of Dengue Illness in the Americas
Economic Impact of Dengue Illness in the Americas
复制标题
DOI：
10.4269/ajtmh.2011.10-0503
复制
发表时间：
2011-02-01
影响因子：
3.3
通讯作者：
Dayan, Gustavo H.
中科院分区：
文献类型：
--
作者：
Shepard, Donald S.;Coudeville, Laurent;Dayan, Gustavo H.
登革热流行国家日益沉重的负担以及以前未受影响国家的疫情爆发强调了评估这种疾病的经济影响的必要性。本文综合现有研究，从社会角度计算美洲登革热疾病的经济负担。主要数据来源包括 2000 年至 2007 年国家病例报告数据、疾病研究的预期成本以及对国家常规监测系统漏报情况进行量化的分析。据估计，美洲的登革热疾病平均每年造成 21 亿美元的损失（以 2010 年美元计算），敏感性分析的范围为 1-40 亿美元，并且每年的差异很大。结果突显了美洲登革热造成的巨大经济负担。登革热的负担超过了其他病毒性疾病，例如人乳头瘤病毒（HPV）或轮状病毒。由于这项研究不包括某些组成部分（例如病媒控制），因此它可能仍然低估了登革热的总体经济后果。
The growing burden of dengue in endemic countries and outbreaks in previously unaffected countries stress the need to assess the economic impact of this disease. This paper synthesizes existing studies to calculate the economic burden of dengue illness in the Americas from a societal perspective. Major data sources include national case reporting data from 2000 to 2007, prospective cost of illness studies, and analyses quantifying underreporting in national routine surveillance systems. Dengue illness in the Americas was estimated to cost $2.1 billion per year on average (in 2010 US dollars), with a range of $1-4 billion in sensitivity analyses and substantial year to year variation. The results highlight the substantial economic burden from dengue in the Americas. The burden for dengue exceeds that from other viral illnesses, such as human papillomavirus (HPV) or rotavirus. Because this study does not include some components (e.g., vector control), it may still underestimate total economic consequences of dengue.